NPI: 1063477727 · FARMINGTON, NM 87401 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/18/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/18/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 44,992 | $787K |
| 2019 | 35,860 | $502K |
| 2020 | 34,057 | $983K |
| 2021 | 36,086 | $1.09M |
| 2022 | 27,340 | $361K |
| 2023 | 21,915 | $550K |
| 2024 | 13,702 | $379K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 90,452 | 6,583 | $3.16M |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 1,583 | 299 | $914K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 50,883 | 3,636 | $338K |
| J1756 | Injection, iron sucrose, 1 mg | 12,413 | 3,252 | $80K |
| A4657 | Syringe, with or without needle, each | 5,653 | 4,887 | $61K |
| J1270 | Injection, doxercalciferol, 1 mcg | 24,071 | 2,148 | $59K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 927 | 588 | $24K |
| 83970 | 3,930 | 3,596 | $7K | |
| 82728 | 3,534 | 3,246 | $2K | |
| 82108 | 1,045 | 952 | $2K | |
| 83550 | 3,372 | 3,086 | $2K | |
| 83540 | 3,610 | 3,300 | $1K | |
| 85041 | 5,080 | 4,520 | $964.79 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 178 | 118 | $872.96 |
| 82570 | 85 | 39 | $666.81 | |
| 85048 | 5,017 | 4,466 | $650.36 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,484 | 961 | $450.86 |
| J3370 | Injection, vancomycin hcl, 500 mg | 37 | 12 | $351.49 |
| 90674 | 165 | 157 | $277.24 | |
| G0008 | Administration of influenza virus vaccine | 121 | 118 | $191.53 |
| 90662 | 20 | 20 | $169.10 | |
| 90732 | 28 | 27 | $116.56 | |
| 90677 | 22 | 22 | $38.42 | |
| 87340 | 28 | 28 | $7.24 | |
| 86706 | 16 | 16 | $4.38 | |
| G0009 | Administration of pneumococcal vaccine | 44 | 43 | $3.48 |
| 84540 | 15 | 12 | $2.48 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 139 | 134 | $0.00 |